Showing results for Diabetes

INDIANAPOLIS—Carmella Evans-Molina, MD, PhD, has been appointed director of the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine. Evans-Molina is the center’s second appointed director since it received designation from the National Institutes of Health in 2015. The center’s mission is to bring cutting-edge research tools to diabetes investigators at […]

It is well understood that people with diabetes have an increased risk for a number of other health complications—including cancer. Last year, when Indiana University School of Medicine researchers demonstrated that inflammation can increase risk for leukemia, they wondered if it was also the culprit that placed people with diabetes at a higher risk for […]

A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment. This research, funded […]

Presented on June 9 in San Francisco at the 2019 American Diabetes Association’s 79th Scientific Sessions and published in the New England Journal of Medicine, findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study show a drug that targets the immune system can delay Type 1 diabetes a median of 2 years in children and adults at […]

Indiana University researchers and physicians announced progress toward their bold goals of developing cures and preventive treatments for devastating diseases prevalent among Indiana residents.

Indiana University School of Medicine was recently awarded a five-year, $1.9 million grant by to study diabetic retinopathy, a long-term, vision-threatening complication of diabetes.